Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

2011220 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Allergy Asthma & Immunology

Volume 107, Issue 6, pp. 529-537.e2

Field-Weighted Citation Impact: 10.06